n van beveren
n van beveren
Antes Groep Rotterdam / Erasmus MC dept. psychiatry / Erasmus MC dept. neuroscience
Geverifieerd e-mailadres voor deltapsy.nl
Titel
Geciteerd door
Geciteerd door
Jaar
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
4122017
Identification of a biological signature for schizophrenia in serum
E Schwarz, PC Guest, H Rahmoune, LW Harris, L Wang, FM Leweke, ...
Molecular psychiatry 17 (5), 494-502, 2012
2352012
Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene–environment interaction: objectives, sample characteristics, recruitment …
N Korver, PJ Quee, HBM Boos, CJP Simons, L de Haan, ...
International journal of methods in psychiatric research 21 (3), 205-221, 2012
2112012
Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia
E Schwarz, R Izmailov, M Spain, A Barnes, JP Mapes, PC Guest, ...
Biomarker Insights 5, BMI. S4877, 2010
1802010
Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients
RC Drexhage, L van der Heul-Nieuwenhuijsen, RC Padmos, ...
International Journal of Neuropsychopharmacology 13 (10), 1369-1381, 2010
1602010
An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro-and anti-inflammatory forces
RC Drexhage, TA Hoogenboezem, D Cohen, MA Versnel, WA Nolen, ...
International Journal of Neuropsychopharmacology 14 (6), 746-755, 2011
1492011
Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia
PC Guest, E Schwarz, D Krishnamurthy, LW Harris, FM Leweke, ...
Psychoneuroendocrinology 36 (7), 1092-1096, 2011
1462011
Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naive schizophrenia patients
PC Guest, L Wang, LW Harris, K Burling, Y Levin, A Ernst, MT Wayland, ...
Molecular psychiatry 15 (2), 118-119, 2010
1462010
Treatment adherence therapy in people with psychotic disorders: randomised controlled trial
ABP Staring, M Van der Gaag, GT Koopmans, JP Selten, JM Van Beveren, ...
The British Journal of Psychiatry 197 (6), 448-455, 2010
1422010
Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset
MK Chan, MO Krebs, D Cox, PC Guest, RH Yolken, H Rahmoune, ...
Translational psychiatry 5 (7), e601-e601, 2015
1242015
Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: a meta-analysis
WP Hoen, JG Lijmer, M Duran, RJA Wanders, NJM van Beveren, ...
Psychiatry research 207 (1-2), 1-12, 2013
1182013
AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder
R Van Winkel, NJM Van Beveren, C Simons
Neuropsychopharmacology 36 (12), 2529-2537, 2011
1002011
Physiological responsivity to emotional pictures in schizophrenia
RJ Hempel, JHM Tulen, NJM van Beveren, HG van Steenis, PGH Mulder, ...
Journal of psychiatric research 39 (5), 509-518, 2005
992005
Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways
E Schwarz, NJM van Beveren, J Ramsey, FM Leweke, M Rothermundt, ...
Schizophrenia bulletin 40 (4), 787-795, 2014
852014
High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls
A Vreeker, MPM Boks, L Abramovic, S Verkooijen, AH van Bergen, ...
Psychological medicine 46 (4), 807-818, 2016
672016
Immune and neuroimmune alterations in mood disorders and schizophrenia
RC Drexhage, K Weigelt, N van Beveren, D Cohen, MA Versnel, ...
International review of neurobiology 101, 169-201, 2011
652011
TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU. 1 as important transcription factors
K Weigelt, LA Carvalho, RC Drexhage, A Wijkhuijs, H de Wit, ...
Brain, behavior, and immunity 25 (6), 1162-1169, 2011
612011
Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled …
LJ van Nimwegen, L de Haan, NJM van Beveren, M van der Helm, ...
The Canadian Journal of Psychiatry 53 (6), 400-405, 2008
612008
The effect of antipsychotic medication on facial affect recognition in schizophrenia: a review
RJ Hempel, JA Dekker, NJM van Beveren, JHM Tulen, MW Hengeveld
Psychiatry research 178 (1), 1-9, 2010
602010
Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis
L van Nimwegen, L de Haan, N van Beveren, W Laan, W van den Brink, ...
Journal of clinical psychopharmacology 28 (2), 214-218, 2008
542008
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20